Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer

NCT06535893 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: TN
DRUG: TN-1

Sponsor

Nagoya City University

Collaborators

[object Object]